Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekDrug Channels ↗
By Bryce Platt, PharmD For years, Medicare Part D plans often preferred high-list/high-rebate branded multiple…
The WeekSTAT News ↗
As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequenc…
The WeekAJMC ↗
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity…
The WeekBioPharma Dive ↗
For 2029, a federal rule proposes closing a "loophole" that protects medicines transitioning from intravenous …
The WeekFiercePharma ↗
Astellas CEO explained to Fierce the company's new five-year plan. A Takeda candidate beat Bristol Myers Squib…
The WeekFierceBiotech ↗
Genentech vice presidents Vishva Dixit, Man-Wah Tan and Todd McDevitt are among the casualties in another roun…
The WeekBriefing
Eli Lilly, Biogen, Eisai, and Genentech sponsor a new Alzheimer’s-focused podcast as pharma marketing leans de…
The WeekBioPharma Dive ↗
For sterile injectables, key early decisions can have a significant impact on the products' development.…
The WeekSTAT News ↗
Medicaid cuts and fraud crackdown trickle down to states, threatening people with disabilities.…
The WeekFiercePharma ↗
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansion…
The WeekFierceBiotech ↗
Staring down a $6 billion patent cliff for its prostate cancer drug Xtandi, Astellas aims to counter the inevi…
The WeekBriefing
STAT News spotlighted obesity drugs in development, peptide therapies going mainstream, and a record biotech I…
The WeekAJMC ↗
Paul Richardson, MD, Calls Mezigdomide "CAR T in a Pill" for Patients With R/R Multiple Myeloma…
The WeekFiercePharma ↗
The accelerated approval for Jazz Pharmaceuticals' small cell lung cancer drug Zepzelca may once again be in j…
The WeekFierceBiotech ↗
Over-the-counter drugmaker Perrigo Company is washing its hands of chief executive Patrick Lockwood-Taylor, wh…
The WeekBriefing
Belgium, the Netherlands, Luxembourg, Austria, and Ireland jointly called for EU-level coordination on pharmac…
The WeekFiercePharma ↗
An independent research firm is reviewing data on Amgen's Tavneos as the company prepares for a hearing with t…
The WeekFierceBiotech ↗
Boehringer Ingelheim's Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared …
The WeekBriefing
The Trump administration proposed changes aimed at closing a loophole in Medicare’s drug price negotiation fra…
The WeekFiercePharma ↗
The Trump administration is floating a proposal to establish a permanent framework for the Medicare drug price…
The WeekFierceBiotech ↗
Christelle Huguet, Ph.D., Ipsen's executive vice president and head of R&D, sits down with Fierce Healthca…
The WeekAJMC ↗
Specialty Pharmacy Drives Advanced Therapy Access: Fran Gregory, PharmD…
The WeekAJMC ↗
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology…
The WeekAJMC ↗
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.